Rajathi Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 1.00 M
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2010
- Open Charges ₹ 12.75 Cr
About Rajathi Biotech
Rajathi Biotech Private Limited (RBPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 August 2006 and has a history of 18 years and five months. Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2010. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹12.75 Cr.
Rajasekar Urmila and Kalaiselvan Deepa serve as directors at the Company.
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01112TN2006PTC061001
- Company No.
061001
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2006
- Date of AGM
30 May 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Rajathi Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajasekar Urmila  | Additional Director | 20-Jan-2011 | Current |
| Kalaiselvan Deepa | Additional Director | 20-Jan-2011 | Current |
Financial Performance of Rajathi Biotech.
Enhance accessibility to Rajathi Biotech's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Rajathi Biotech?
Unlock access to Rajathi Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹12.75 Cr
₹0
Charges Breakdown by Lending Institutions
- Pegasus Group One Trust Vii - Pegasus Assets Reconstruction Private Limited : 12.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Mar 2011 | Pegasus Group One Trust Vii - Pegasus Assets Reconstruction Private Limited | ₹12.75 Cr | Open |
How Many Employees Work at Rajathi Biotech?
Unlock and access historical data on people associated with Rajathi Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rajathi Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rajathi Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
